✦ LIBER ✦

Eli lilly disclaimer

Book ID: 114101665
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 11 KB
Volume: 90
Category: Article
ISSN: 0090-8258
DOI: 10.1016/s0090-8258(03)00494-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eli Lilly

✍ Hartley, Frank 📂 Article 📅 1977 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

Lilly (Eli) & Co.

📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) ⚖ 100 KB

Lilly (Eli) & Co.

📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) ⚖ 116 KB

Lilly (Eli) & Co.

📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) ⚖ 242 KB

Lilly (Eli) & Co.

📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) ⚖ 107 KB

## Abstract **Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)** Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa®, Strattera®, Prozac®, Cymbalta® and Symbya

Lilly (Eli) & Co.

📂 Article 📅 2004 🏛 Wiley (John Wiley & Sons) ⚖ 69 KB

## Abstract **Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC:325412)** Eli Lilly discovers, develops, manufactures, and sells pharmaceuticals and animal health products. Neuroscience products include __Prozac__®, __Zyprexa__®, __Strattera__™__Darvon__®, __Permax__®, __Symbyax__®and __Sarafem__™. Endocri